This product is a broad-spectrum antiviral drug. Its mechanism of action is mainly to inhibit inosine dehydrogenase, block the conversion of inosine-phosphate to xanthine-phosphate, thereby inhibiting nucleic acid synthesis and preventing viral replication.

This product is a broad-spectrum antiviral drug. Its mechanism of action is mainly to inhibit inosine dehydrogenase, block the conversion of inosine-phosphate to xanthine-phosphate, thereby inhibiting nucleic acid synthesis and preventing viral replication.

This product can inhibit the synthesis of prostaglandins and has analgesic, antipyretic and anti-inflammatory effects.

This product is a quinolone antibacterial drug. It has high antibacterial activity against Enterobacteriaceae such as Escherichia coli, Shigella, Klebsiella, Proteus, Enterobacter, etc.; Haemophilus influenzae and Neisseria gonorrhoeae are also highly sensitive to this product; it also has certain antibacterial effects on Pseudomonas such as Acinetobacter, Pseudomonas aeruginosa, Staphylococcus, Pneumococcus, and hemolytic Streptococcus. This product acts on the A subunit of DNA helicase in bacterial cells, inhibiting the synthesis and replication of DNA and exerting a bactericidal effect.

This product is a third-generation quinolone broad-spectrum antibacterial drug, and its mechanism of action is to inhibit bacterial DNA helicase. This product has antibacterial activity against Gram-negative bacteria, Gram-positive bacteria and some anaerobic bacteria. There is no cross-resistance between this product and other types of antibacterial drugs. This product has high antibacterial activity against Enterobacteriaceae such as Escherichia coli, Shigella, Klebsiella, Proteus, Enterobacter, etc.; influenza bacillus, gonococci, etc. are also highly sensitive to this product; it also has certain antibacterial effects on Pseudomonas such as Acinetobacter and Pseudomonas aeruginosa, Staphylococcus, pneumococcus, hemolytic streptococci, etc.